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Structural insights into the molecular
mechanism of the m6A writer complex
Paweł S´ledz´, Martin Jinek*
Department of Biochemistry, University of Zurich, Zurich, Switzerland
Abstract Methylation of adenosines at the N6 position (m6A) is a dynamic and abundant
epitranscriptomic mark that regulates critical aspects of eukaryotic RNA metabolism in numerous
biological processes. The RNA methyltransferases METTL3 and METTL14 are components of a
multisubunit m6A writer complex whose enzymatic activity is substantially higher than the activities
of METTL3 or METTL14 alone. The molecular mechanism underpinning this synergistic effect is
poorly understood. Here we report the crystal structure of the catalytic core of the human m6A
writer complex comprising METTL3 and METTL14. The structure reveals the heterodimeric
architecture of the complex and donor substrate binding by METTL3. Structure-guided
mutagenesis indicates that METTL3 is the catalytic subunit of the complex, whereas METTL14 has a
degenerate active site and plays non-catalytic roles in maintaining complex integrity and substrate
RNA binding. These studies illuminate the molecular mechanism and evolutionary history of
eukaryotic m6A modification in post-transcriptional genome regulation.
DOI: 10.7554/eLife.18434.001
Introduction
Methylation of the amino group at the N6 position in adenine nucleobases (m6A) has emerged as a
dynamic posttranscriptional RNA modification (Fu et al., 2014; Liu and Pan, 2016; Meyer and Jaf-
frey, 2014; Yue et al., 2015). As the most abundant internal modification in eukaryotic messenger
and long non-coding RNAs (Dominissini et al., 2013; Meyer et al., 2012), m6A has been shown to
regulate the processing (Alarco´n et al., 2015b; Xiao et al., 2016), translation (Lin et al., 2016;
Wang et al., 2015) and stability (Wang et al., 2014a) of cellular transcripts. In mRNAs, the modifica-
tion is typically found clustered around the stop codon and within 3’ untranslated regions
(Dominissini et al., 2012; Meyer et al., 2012); the presence of m6A in 5’ untranslated regions has in
turn been shown to promote 5’ cap-independent translation (Meyer et al., 2015). m6A is implicated
in controlling stem cell differentiation and embryonic development (Batista et al., 2014;
Chen et al., 2015; Geula et al., 2015; Wang et al., 2014b), the mammalian circadian clock
(Fustin et al., 2013), as well as in stress responses such as heat shock (Zhou et al., 2015). The modi-
fication is reversible due to the interplay of methyltransferase (MTase) ‘writer’ (Liu et al., 2014) and
demethylase ‘eraser’ (Jia et al., 2011; Zheng et al., 2013) enzymes. Transcripts containing m6A
marks are specifically recognized and regulated by ‘reader’ proteins, in particular members of the
YTH domain family (Stoilov et al., 2002). The cytoplasmic protein YTHDF2 specifically recognizes
and destabilizes m6A-modified RNAs by promoting their localization to processing (P-) bodies
(Wang et al., 2014a), while YTHDF1 stimulates mRNA translation by interactions with translation ini-
tiation factors (Wang et al., 2015). The nuclear YTHDC1 protein modulates pre-mRNA splicing by
recruiting and modulating splicing factors (Xiao et al., 2016). Another m6A reader, HNRNPA2B1,
has been shown to promote pri-microRNA processing through interactions with the Microprocessor
complex (Alarco´n et al., 2015a).
The m6A RNA modification is catalyzed in the nucleus by a multiprotein writer complex containing
the putative methyltransferases METTL3 and METTL14 (Bokar et al., 1997; Liu et al., 2014;
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Schwartz et al., 2014). The two subunits interact directly with each other and further associate with
Wilms tumor 1-associated protein (WTAP) (Liu et al., 2014; Ping et al., 2014; Schwartz et al.,
2014). WTAP does not have MTase activity but is required for efficient RNA methylation in vivo and
for localization of METTL3 and METTL14 to nuclear speckles (Ping et al., 2014). The m6A writer
complex catalyzes the transfer of a methyl group from the donor substrate S-adenosyl methionine
(SAM) to the adenine nucleobases in acceptor RNA substrates (Bokar et al., 1997). The complex
preferentially modifies substrate RNAs conforming to the consensus sequence GGACU but other-
wise appears to have little specificity for structural features in its RNA substrates (Liu et al., 2014).
Both METTL3 and METTL14 have been shown to have weak m6A methyltransferase activity in isola-
tion. However, physical interaction between METTL3 and METTL14 results in substantially higher
MTase activity than the sum of the activities of the individual methyltransferase subunits (Liu et al.,
2014). Despite recent advances in understanding the biological roles of m6A modification, the
molecular architecture of the m6A writer complex and its mechanism of RNA methylation are poorly
understood. In particular, the molecular basis for the synergistic enhancement of MTase activity
within the m6A writer complex is unknown.
To shed light on the molecular mechanism of m6A RNA methylation, we determined crystal struc-
tures of the catalytic core of the m6A writer complex comprising METTL3 and METTL14 methyltrans-
ferase subunits. The structures reveal the molecular architecture of the complex and highlight
specific features involved in complex assembly, substrate recognition and catalysis. Crucially, our
structural and biochemical data imply that METTL3 is the sole catalytic subunit of the complex, while
METTL14 plays non-catalytic roles in complex stabilization and substrate RNA recruitment. These
findings advance our mechanistic understanding of the m6A modification in post-transcriptional
genome regulation.
Results
Identification and structure determination of a minimal core m6A writer
complex
The m6A writer complex contains two putative catalytic subunits - METTL3 and METTL14. Previous
studies have shown that METTL3 and METTL14 physically interact with each other and that their
association has a synergistic effect on the catalytic activity of the complex (Liu et al., 2014). To
obtain structural insights into the molecular architecture and mechanism of the m6A writer complex,
we sought to determine the crystal structure of the catalytic core of the complex comprising the two
methyltransferase (MTase) subunits (Figure 1A). To this end, we co-expressed human METTL3 and
METTL14 in insect cells. The purified METTL3-METTL14 complex was catalytically active (Figure 1B)
but failed to crystallize. Both METTL3 and METTL14 polypeptides contain a central MTA-70 methyl-
transferase domain (Bujnicki et al., 2002). METTL3 additionally contains an N-terminal region har-
boring two putative CCCH zinc finger motifs, whereas in METTL14, the MTA-70 domain is flanked
by N- and C-terminal extensions containing low-complexity sequences (Iyer et al., 2016)
(Figure 1A). To identify protein constructs amenable to crystallization, the full-length METTL3-
METTL14 complex was subjected to limited proteolysis with chymotrypsin and N-terminal sequenc-
ing. Based on these experiments, we engineered N- and C-terminally truncated forms of both
METTL3 and METTL14, comprising residues 354–580 and 107–395, respectively. The MTase activity
of the truncated METTL3-METTL14 dimer was reduced to background level, indicating that the ter-
minal extensions are required for efficient substrate RNA binding or catalysis. Further experiments
using complexes in which only METTL3 or METTL14 was truncated showed that the catalytic activity
is contingent upon the presence of full-length METTL3, while the N- and C-terminal extensions flank-
ing the central region comprising residues 107–395 in METTL14 are dispensable (Figure 1B). The
truncated METTL3-METTL14 complex was crystallized and its structure solved by a single-wave-
length anomalous diffraction approach utilizing the anomalous signal of native sulfur atoms. Experi-
mentally-phased electron density maps revealed the presence of a single molecule of the donor
product S-adenosyl homocysteine (SAH), serendipitously co-purified with the complex, in the
METTL3 active site (Figure 1—figure supplement 1A). High-resolution native data were subse-
quently measured from a METTL3-METTL14 crystal grown in the presence of SAH and a short m6A-
containing oligonucleotide. However, the RNA oligonucleotide was not evident in electron density
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maps. The final atomic model, containing a single METTL3-METTL14 dimer in the asymmetric unit,
was refined at a resolution of 1.85 A˚ with an Rfree of 19.0%, working R of 15.7%, and good stereo-
chemistry (Table 1). We additionally co-crystallized the METTL3-METTL14 core complex in the pres-
ence of the donor substrate S-adenosyl methionine (SAM) (Figure 1—figure supplement 1B). Using
these crystals, a structure of the METTL3-METTL14 complex, in which the co-purified SAH product
was exchanged by SAM, was determined at a resolution of 1.9 A˚ and refined to an Rfree and Rwork
values of 18.6% and 15.7%, respectively. No additional electron density attributable to SAM or SAH
could be observed in the proximity of METTL14 in the two structures. Disulfide bridge formation
was observed between Cys338METTL14 and Cys388METTL14 (Figure 1—figure supplement 2A). The
MTase activity of the METTL3-14 complex has previously been reported to be sensitive to reducing
agents (Li et al., 2016), suggesting that disulfide bond formation could play a role in regulating the
catalytic activity of the complex. However, substitution of Cys338METTL14 with alanine had little
impact on MTase activity, indicating that disulfide bond formation in METTL14 is not required for
the function of the m6A writer complex (Figure 1—figure supplement 2B).
METTL3 and METTL14 form a pseudosymmetric dimer
The structures of the METTL3-METTL14 complex reveal that the two methyltransferase subunits
form a compact pseudosymmetric heterodimer with overall dimensions of 80  40  35 A˚
(Figure 2A). Both METTL3 and METTL14 belong to the Group I clade of eukaryotic N6A-MTases
(Iyer et al., 2016). The core of each methyltransferase subunit is formed by a Rossman fold domain
comprising a central, curved, eight-stranded beta sheet flanked by four alpha helices (Figure 2B,
Figure 2—figure supplement 1). The METTL3 and METTL14 MTase domains dimerize through an
extensive interface that buries 2055 A˚2 of solvent-accessible surface area per subunit. The symmetric
part of the dimerization interface is formed by strands b4–5 and helix a4 of each MTase domain
(Figure 2C), and involves a network of hydrogen bonding interactions as well as hydrophobic con-
tacts (Figure 2D). The hydrophobic region of the METT3-METTL14 interface, centered on strands
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Figure 1. Domain composition and methyltransferase activity of METTL3-METTL14. (A) Domain composition of METTL3 and METTL14. Predicted
CCCH zinc finger motifs in the N-terminal region of METTL3 are shown in green. The crystallized METTL3-METTL14 complex contained the MTA-70
methyltransferase domain of METTL3 (residues 354–580, highlighted in blue) and a METTL14 construct (residues 117–395, highlighted in pink)
comprising the MTA-70 domain preceded by an N-terminal extension (denoted HM). (B) Methyltransferase activities of the full-length METTL3-
METTL14 complex, and complexes containing truncated METTL3 and METTL14 proteins used for the structure determination. The activities were
determined by measuring the concentration of methylated RNA product using a m6A-specific antibody in an enzyme-linked immunosorbent assay. The
activities are represented as fractions of the activity of WT complex. Reactions lacking the donor substrate SAM were performed to determine
background signal in the assay due to non-specific antibody binding. Error bars represent mean ± standard error of the mean (s.e.m) of three
independent replicates.
DOI: 10.7554/eLife.18434.002
The following figure supplements are available for figure 1:
Figure supplement 1. Methyl group donor substrate and product binding in the METTL3 active site.
DOI: 10.7554/eLife.18434.003
Figure supplement 2. METTL3-METTL14 is catalytically active under reducing conditions.
DOI: 10.7554/eLife.18434.004
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b4–5, is capped by the side chain of Ile134METTL14 from an N-terminal extension of METTL14 com-
prising residues Asn117-Asp136METTL14 (Figure 1A). The METTL14 N-terminal extension, which lacks
secondary structure except for a short alpha-helical motif (Tyr119-Thr126METTL14), breaks the overall
pseudo-C2 symmetry of the heterodimer and shields the hydrophobic dimerization interface from
solvent exposure. Of note, we were unable to express soluble METTL3-METTL14 complexes lacking
the N-terminal METTL14 extension. Unlike METTL14, METTL3 lacks equivalent amino acid residues
in the region upstream of the methyltransferase domain. Finally, the dimerization interaction is rein-
forced by two partially disordered loops, one from each subunit (residues Arg468-Lys480METTL3 and
Table 1. Data collection and refinement statistics.
SAM complex SAH complex Sulfur-SAD
X-ray source SLS X06DA (PXIII) SLS X06DA (PXIII) SLS X06DA (PXIII)
Space group P 32 2 1 P 32 2 1 P 32 2 1
Cell dimensions
a, b, c (A˚) 63.95, 63.95, 225.86 63.82, 63.82, 225.63 64.02, 64.02, 226.84
a, b, g (˚) 90.0, 90.0, 120.0 90.0, 90.0, 120.0 90.0, 90.0, 120.0
Wavelength (A˚) 1.03965 1.03965 2.07334
Resolution (A˚) (2.02–1.90) (1.96–1.85) (2.80–2.70)
Rsym (%) 8.9 (70.6) 7.5 (68.9) 16.5 (97.3)
CC1/2 99.9 (89.0) 100.0 (87.5) 100.0 (97.9)
I / sI 21.89 (3.42) 24.51 (3.55) 47.24 (8.03)
Observations 846792 (131654) 906619 (142053) 3073142 (279442)
Unique reflections 81250 (13087) 87473 (14080) 28625 (2970)
Multiplicity 10.4 (10.1) 10.4 (10.1) 107.4 (94.1)
Completeness (%) 99.9 (99.2) 99.9 (99.3) 100.0 (100.0)
Refinement
Resolution (A˚) 44.62–1.90 49.65–1.85
No. reflections 43271 46510
Rwork/Rfree 0.1567/0.1855 0.1569/0.1899
No. atoms
Protein 3549 3571
Ligands 32 31
Water 359 405
B-factors
Mean 28.76 29.89
Protein 28.17 29.08
Ligands 25.06 22.72
Water 35.28 37.64
R.m.s. deviations
Bond lengths (A˚) 0.011 0.011
Bond angles (˚) 1.088 1.126
Ramachandran plot
% Favored 98.1 98.8
% Allowed 1.9 1.2
% Outliers 0 0
Values in parentheses denote highest resolution shell.
DOI: 10.7554/eLife.18434.005
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Figure 2. METTL3 and METTL14 form an asymmetric dimer. (A) Overall structure of METTL3-METTL14 heterodimer. METT3 is colored blue; METTL14 is
colored pink. The color coding is used throughout the manuscript. Bound SAM donor substrate is shown in stick format and colored yellow. (B)
Sequence alignment of human METLL3 and METTL14. The alignment was generated using T-Coffee (Di Tommaso et al., 2011) and displayed using
Espript (Gouet et al., 1999). Invariant residues are highlighted in red; conserved residues are highlighted in yellow. Amino acid residues involved in
donor or acceptor substrate binding are marked with colored triangles. Secondary structure elements in METTL3 are depicted above the aligned amino
acid sequences. (C) Enlarged view of the dimerization interface (orientation as in the left panel of A). (D) N-terminal helical motif of METTL14 shields the
hydrophobic part of the METTL3-METTL14 interface from the solvent exposure by capping it with Ile134Mettl14. (E) Detailed views of intersubunit
interactions mediated by loops Arg468-Lys480METTL3 and Lys266-Arg283METTL14 containing hydrophobic residues Trp475-Leu476METTL3 and Val280-
Phe281METTL14, respectively.
DOI: 10.7554/eLife.18434.006
The following figure supplements are available for figure 2:
Figure supplement 1. Structural comparisons of the methyltransferase domains of METTL3 and METTL14.
DOI: 10.7554/eLife.18434.007
Figure 2 continued on next page
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Lys266-Arg283METTL14), that reach over and insert an aromatic residue (Trp475METTL3 and Phe281-
METTL14, respectively) into a hydrophobic pocket in the other subunit (Figure 2E).
The structure of the human METTL3-METTL14 complex has been recently reported by two other
studies (Wang et al., 2016a, 2016b). Both studies utilized a slightly different METTL3-METTL14 con-
struct, yielding a different crystal form of the complex. Overall, all structures are in good agreement
with one another, the major difference being the absence of an ordered polypeptide chain linking
the N-terminal helical motif of METTL14 and the methyltransferase domain in the structure reported
in this study (Figure 2—figure supplement 2). Additionally, the structure reported in this study lacks
a C-terminal helix in METTL14 due to a different choice of METTL14 domain boundaries and instead
contains the Cys338METTL14–Cys388METTL14 disulfide bridge. Further structural differences between
the different crystal forms can be attributed to the intrinsic flexibility of loop regions and differences
in crystal packing (Figure 2—figure supplement 2).
Individually, the MTase domains of METTL3 and METTL14 are highly similar to other Rossman
fold-containing methyltransferases. The closest structural homologs include bacterial adenine-spe-
cific DNA methyltransferases MboIIa (Osipiuk et al., 2003) (rmsd of 2.8 A˚ over 167 Ca atoms for
METTL3, 2.7 A˚ over 165 Ca atoms for METTL14) and RsrI (Scavetta et al., 2000) (rmsd of 2.8 A˚
over 172 Ca atoms for METTL3, 2.8 A˚ over 171 Ca atoms for METTL14). However, the dimerization
mode observed in the METTL3-METTL14 complex is distinct from these other multisubunit RNA
methyltransferase enzymes such as Bud23-Trm12 (Le´toquart et al., 2014) or Trm9-Trm112
(Le´toquart et al., 2015) and closely resembles the homodimerization mode of prokaryotic N6A
DNA methyltransferases such as EcoP15I (Figure 3) (Gupta et al., 2015).
Donor and acceptor substrate binding in the METTL3 active site
The donor substrate binding site in METTL3 is located at the carboxy-termini of strands b1, b7 and
b8, where the SAM donor is bound by multiple hydrogen bonding interactions (Figure 4A). The
SAM binding site is enclosed from opposite sides by partially disordered loop containing Asp395-
Figure 2 continued
Figure supplement 2. Comparisons of METTL3-METTL14 complex structures.
DOI: 10.7554/eLife.18434.008
A B
Figure 3. Dimerization of METTL3-METTL14 is similar to homodimeric N6-adenosine DNA methyltransferases. (A) Structure of dimeric N6-adenosine
DNA methyltransferase EcoP15I bound to a DNA substrate (Gupta et al., 2015). (B) Inset showing detail of the dimer interface of EcoP15I (colored
gray) superimposed with the METTL3-METTL14 (METTL3 colored in blue, METTL14 in pink).
DOI: 10.7554/eLife.18434.009
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Thr408METTL3 (termed active site loop 1, ASL1) and a fully ordered loop comprising residues Arg508-
Lys513METTL3 (hereafter termed active site loop 2, ASL2). A conserved DPPW motif (Asp395-
Pro398METTL3) in ASL1, characteristic of N6-adenosine methyltransferases (Iyer et al., 2016), is likely
involved in coordinating the adenine group of the acceptor substrate. The methyl group of SAM is
positioned directly above the DPPW motif, while the adenine moiety is inserted in a hydrophobic
pocket lined with Ile378METTL3, Pro397METTL3, Leu409METTL3 and Phe534METTL3, and is coordinated
by hydrogen binding interactions to Asp377METTL3 and the main-chain amide nitrogen of Ile378-
METTL3. The ribose 2’ and 3’ hydroxyl groups are hydrogen bonded to Asn549METTL3 and
Gln550METTL3, respectively. The amino group of the methionine moiety is hydrogen bonded to
Arg536, while the carboxyl group is surrounded by the side chains of His512METTL3, Lys513METTL3,
Arg536METTL3, and His538METTL3. Comparisons with the structure of the SAH product-bound com-
plex reveal that the both SAM and SAH molecules adopt very similar conformations except for a
slight rotation of the ribose moiety in SAH (Figure 4B). Additional ordering of ASL1 is observed in
the SAH-bound structure, whereby Tyr406METTL3 caps the SAH product and makes a hydrogen
bonding interaction with Ser511METTL3 in ASL2. Taken together, the structures of the SAM- and
SAH-bound METTL3-14 complexes thus reveal the METTL3 active site in the pre- and post-catalytic
states, respectively.
Superposition of METTL3 onto the structure of other methyltransferase-substrate complexes such
as EcoP15I suggests a mechanism for acceptor substrate recognition, in which the adenine moiety of
the acceptor substrate is inserted between ASL1 and ASL2 (Figure 4C). The N6 amino group is
located such that it is hydrogen-bonded to the side chain amide group of Asp395METTL3, the
hydroxyl group of Tyr406METTL3 and the main chain carbonyl of Pro396METTL3 within the conserved
DPPW motif. These interactions activate the amino group for nucleophilic attack on the methyl
group in SAM. Additionally, a rearrangement of the ASL1, such that Trp398METTL3 forms a p-p stack-
ing interaction with the acceptor adenine, would be expected to occur upon acceptor substrate
binding.
METTL14 contains a degenerate active site and lacks catalytic activity
In comparison with METTL3, the MTase domain of METTL14 adopts a very similar fold, superimpos-
ing with an rmsd of 1.65 A˚ over 199 aligned residues (Figure 2B, Figure 2—figure supplement 1).
However, neither SAM nor SAH were observed to be bound to METTL14 in the METTL3-14 complex
structures. Modeling a molecule of SAM in the METTL14 active site reveals that the binding would
be precluded by steric clashes between the adenine moiety and the side chains of Trp211METTL14
and Pro362METTL14 in the absence of compensatory structural changes in METTL14. Moreover,
METTL14 lacks residues that could form hydrogen-bonding contacts to the ribose hydroxyls in SAM,
as residues Asn549METTL3 and Gln550METTL3 correspond to Pro362METTL14 and Thr363METTL14,
respectively. Additionally, the putative acceptor binding site in METTL14 is occluded by the side
chains of Tyr198METTL14, Tyr199METTL14 and Ile324METTL14 projecting from loops corresponding to
ASL1 and ASL2 in METTL3 (Glu192-Cys210METTL14 and Pro319-Lys326METTL14, respectively)
(Figure 5A). The equivalent of the METTL3 DPPW motif, Glu192-Leu1195METTL14 (EPPL), is thus not
accessible and moreover lacks an aromatic moiety required for the stacking interaction with the
acceptor adenine, (Figure 5A). Collectively, these observations suggest that METTL14 contains a
degenerate active site that is unable to accommodate donor and acceptor substrates, implying that
METTL14 is catalytically inactive. To test this hypothesis, we targeted putative active site residues
implicated in donor substrate binding and catalysis in METTL3 and METTL14 by site-directed muta-
genesis, and assayed the methyltransferase activities of resulting complexes using an RNA oligonu-
cleotide containing the consensus m6A methylation sequence GGACU. Substitutions of
Asp395METTL3 or Asn549/Gln550METTL3 to alanine reduced the methyltransferase activity of the com-
plex to background levels (Figure 5B). In contrast, alanine substitutions of Glu192METTL14 or Pro362/
Thr363METTL14 targeting the putative active site in METTL14 had little effect on the MTase activity of
the METTL3-14 complex (Figure 5B). These results indicate that the catalytic activity of the complex
is restricted to the METTL3 active site and suggest that METTL14 likely plays a non-catalytic role
within the m6A writer complex.
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Figure 4. Methyl group donor substrate and product binding in the METTL3 active site. The active site of METTL3
with (A) the donor substrate SAM and (B) product SAH bound. The ligands are shown in stick format and colored
yellow. Black dashed lines indicate hydrogen bonding interactions. (C) Model of acceptor adenine binding in the
METTL3 active site. Donor (SAM) and acceptor (adenine) substrates are shown in stick format and colored gray.
Figure 4 continued on next page
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Substrate RNA binding by the METTL3-METTL14 dimer
Superimposing the structure of the METTL3-14 complex with structures of EcoP15I and TaqI MTases
bound to DNA substrates (Goedecke et al., 2001; Gupta et al., 2015) suggests two potential bind-
ing modes for the RNA acceptor substrate, depending on whether the acceptor adenine base is
superimposed onto the active site in METTL3 or the corresponding site in METTL14 (Figure 6A,B).
With the acceptor adenine bound in the active site of METTL3, the ribose-phosphate backbone of
the RNA substrate is placed over a positively charged groove located at the interface of the METTL3
and METTL14 subunits (Figure 6C,D). This groove is highly evolutionarily conserved and comprises
residues Arg465METTL3, Arg468METTL3, His474METTL3, His478METTL3 and Arg245METTL14, Arg249-
METTL14, Arg254METTL14 and Arg255METTL14. The last four residues form a positively charged pocket
occupied by a co-crystallized acetate ion, possibly mimicking RNA phosphate group binding
(Figure 6E). These observations suggest that this surface mediates substrate RNA binding and are in
good agreement with the presence of bound donor substrate and product in the METTL3 active site
and lack of catalytic activity in active site mutants of METTL3. In contrast, the corresponding surface
adjacent to the putative active site in METTL14 on the opposite face of the METTL3-14 dimer lacks
evolutionary conservation and is mostly negatively charged (Figure 6D). This argues against sub-
strate RNA binding by this surface and further underscores the notion that METTL14 is catalytically
inactive. To test the hypothesis that the positively charged groove adjacent to the METTL3 active
site at the METT3-METTL14 dimer interface is involved in substrate RNA binding, we substituted
Arg254METTL14 with alanine and assayed the resulting complex for MTase activity. The activity of the
R254AMETTL14 mutant complex was substantially lower than in the wild type (Figure 6F). When
Arg255METTL14 was additionally mutated to alanine, the catalytic activity of resulting R254A/
R255AMETTL14 double mutant complex was reduced to background levels, further suggesting that
these residues are involved in substrate RNA binding (Figure 6G). We additionally tested the
involvement of the amino acid residues in the putative acceptor binding pockets in METTL3 and
Figure 4 continued
The model was generated by superimposing METTL3 with the structure of N6-adenosine DNA methyltransferases
EcoP15I (Gupta et al., 2015).
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Figure 6. The METTL3-METTL14 dimer interface binds substrate RNA. (A) Model of acceptor substrate binding in the active site of METTL3 obtained
by superimposing METTL3 in the METTL3-METTL14 complex structure with the active methyltransferase subunit in the structure of the Mod2Res1
holocomplex of the N6-adenosine DNA methyltransferase EcoP15I bound to substrate dsDNA (PDB entry 4ZCF). For clarity, only the acceptor
adenosine-containing strand of the substrate DNA is shown. METTL3-METTL14 is shown in surface representation with subunits colored as in
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METTL14. Alanine substitution of Tyr406METTL3 reduced the MTase activity of the complex to back-
ground level. In contrast, substitution of Tyr198METTL14 had little effect on MTase activity
(Figure 6F). Collectively, these results suggest that the m6A writer complex contains only one active
site – in METTL3 – and that substrate RNA binding is mediated by a conserved electropositive sur-
face at the interface of the METTL3-14 subunits.
Discussion
Numerous recent studies have established that m6A plays important regulatory roles in eukaryotic
RNA metabolism that impact many aspects of cellular physiology. Despite rapid progress in under-
standing the biological functions of m6A, there have been only limited mechanistic insights into the
basic molecular machinery that installs this epitranscriptomic mark. In this study, we have defined
the catalytic core of the m6A writer complex and determined the structure of its complexes with
methyl group donor substrates and products. Our findings are in good agreement with other recent
structural studies of the m6A writer complex (Wang et al., 2016a, 2016b). The molecular architec-
ture of the METTL3-METTL14 dimer is strikingly similar to that of homodimeric bacterial N6-adeno-
sine DNA methyltransferases such as EcoP15I. This hints at an evolutionary scenario in which the
m6A writer enzyme emerged by the acquisition of a bacterial homodimeric DNA methyltransferase.
Subsequent gene duplication and sequence divergence of the METTL3 and METTL14 subunits may
have driven the specificity switch towards RNA.
The presence of an extensive interaction interface between METTL3 and METTL14 in the complex
suggests that the two methyltransferase subunits form an obligate, constitutive heterodimer, imply-
ing that they are unlikely to be functional in isolation. Of note, we have not been able to express
and purify soluble METTL14 in the absence of METTL3, suggesting that METTL3 is required to stabi-
lize METTL14. Our observations are fully consistent with a recent genetic study showing that knock-
out of either METTL3 or METTL14 in mouse embryonic stem cells resulted in complete loss of m6A
modification in mRNA (Geula et al., 2015). Although both METTL3 and METTL14 have previously
been reported to harbor weak m6A MTase activity (Liu et al., 2014), our structural and biochemical
data indicate that METTL3 is the sole catalytic subunit within the m6A writer complex. Neither SAM
nor SAH was observed to bind to METTL14 in the structures. Moreover, the putative active site in
METTL14 is sterically blocked and lacks specific amino acid residues that would facilitate donor and
acceptor substrate binding. Consistently, engineered mutations in the active site of METTL3 com-
promise the MTase activity of the complex, while corresponding mutations in METTL14 have little or
no effect. These observations suggest that METTL14 is not catalytically active and likely has a two-
fold function in maintaining the integrity of the complex and in facilitating RNA substrate binding,
explaining the synergistic effect of the METTL3-METTL14 interaction on enzymatic activity of the
m6A writer complex.
Based on these results, we propose a model for substrate RNA recognition by the METTL3-
METTL14 complex in which binding of the substrate RNA to a conserved, positively charged inter-
face of the METTL3-METTL4 heterodimer positions the acceptor adenine moiety in the catalytic
pocket of METTL3 (Figure 7). Consistent with the model, mutations of arginine residues at the
METTL3-METTL14 interface substantially reduce the MTase activity of the complex. However, given
that the truncated complex used for crystallographic analysis lacks catalytic activity in vitro compared
Figure 6 continued
Figure 2A. (B) Model of acceptor substrate binding to METTL14 obtained by superimposing METTL14 in the METTL3-METTL14 complex structure with
the active methyltransferase subunit in the EcoP15I-dsDNA substrate complex. (C) Surface electrostatic potential (left) and sequence conservation (right)
shown for the side of the METTL3-METTL14 heterodimer containing the METTL3 active site. The acetate ion and SAM cofactor co-crystallized with the
protein, as well as the acceptor adenosine modeled based on EcoP15I structure are shown in yellow. The surface electrostatic potential was calculated
in Pymol (Schroedinger); sequence conservation was mapped using the Consurf server (Ashkenazy et al., 2010). (D) Electrostatic surface potential and
sequence conservation for the side of the complex corresponding to the degenerate METTL14 catalytic site. (E) Close-up view of the arginine-rich
positively charged acetate ion binding site, proposed to interact with the ribose-phosphate backbone of substrate RNA. (F) Methyltransferase activities
of WT METTL3-METTL14 complex and the alanine mutants of putative RNA substrate binding residues. The activities were measured as in Figure 1B.
(G) Methyltransferase activities of WT and R254A/R255AMETTL14 mutant complex.
DOI: 10.7554/eLife.18434.012
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to the complexes containing full-length METTL3, the N-terminal extension of METTL3 is also
required for the MTase activity of the core m6A complex. It is tempting to speculate that the two
N-terminal CCCH zinc finger motifs of METTL3 are essential for catalytic activity, perhaps by contrib-
uting to specific recognition of the consensus methylation sequence. Interestingly, despite the spa-
tial proximity of the N-terminal extension of METTL14 to the active site of METTL3 (Figure 2A),
additional sequences in the N-terminal low complexity region of METTL14 are dispensable for cata-
lytic activity.
Our results provide a revised model of the molecular mechanism of the METTL3-METTL14 com-
plex that extends beyond the recent structural findings of Wang et al. (2016b), showing that the
crystallized construct is not representative of the catalytically active complex and implicating the
N-terminal region of METTL3 in substrate RNA recognition. Another structural analysis of the
METTL3-METTL14 complex, published while this work was under revision (Wang et al., 2016a), has
corroborated our model and validated the requirement for the METTL3 zinc finger motifs for methyl-
transferase activity. Nevertheless, the molecular mechanism of substrate RNA recognition still awaits
further structural and biochemical characterization. Moreover, the core m6A writer complex associ-
ates in vivo with additional components such as WTAP, whose functions are not fully understood.
Defining the molecular architecture of the m6A writer holocomplex will therefore be a major goal of
future structural studies.
Materials and methods
Protein expression and purification
For biochemical assays, full-length human METTL3-METTL14 complex was prepared by coexpression
using the Sf9 insect cell/baculovirus expression system. A two-cassette baculovirus shuttle vector
was constructed from plasmid 5B (developed by Scott Gradia, UC Berkeley MacroLab, Addgene
#30122) using ligation-independent cloning (LIC). METTL14 was expressed with an N-terminal hexa-
histidine tag. METTL3 was fused to an N-terminal polypeptide sequence comprising a StrepII epi-
tope tag (WSHPQFEK) fused to green fluorescent protein (GFP). This METTL14 fusion construct was
generated by first inserting the METTL14 DNA sequence into the 438-RGFP vector (developed by
Scott Gradia, UC Berkeley MacroLab, Addgene #55221) and then subcloning the fusion construct
into the 5B baculovirus shuttle vector. Recombinant baculoviruses were generated using the Bac-to-
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RNA binding groove
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METTL3 N-terminal 
Zn finger motifs
Figure 7. Proposed model for RNA methylation by the METTL3-METTL14 complex. Binding of the substrate RNA
to a conserved positively charged surface on the asymmetric interface of the METTL3-METTL4 heterodimer
positions the acceptor adenine moiety in the catalytic pocket of METTL3 located defined by ASL1 and ASL2 loops.
METTL3 catalyzes methyl group transfer from SAM to the acceptor adenine moiety. The N-terminal region in of
METTL3, containing two putative CCCH zinc finger motifs, contributes to substrate RNA recognition.
DOI: 10.7554/eLife.18434.013
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Bac kit (Invitrogen) according to manufacturer’s protocol. For protein expression, suspension cul-
tures of Sf9 cells in SF-4 Baculo Express medium (Amimed) were infected at a density of 2.0 
106 ml 1. Cells were harvested 72 hr post infection, resuspended in 20 mM Tris-Cl pH 8.0, 200 mM
KCl, 5 mM imidazole, 10% glycerol, 0.4% Triton-X100, supplemented with Protease Inhibitor Cock-
tail (Roche Diagnostics GmbH, Germany), and lysed by sonication. The protein complex was purified
by Ni-affinity chromatography on Ni-NTA matrix (Qiagen). The affinity tags were removed by diges-
tion with TEV protease, followed by further purification by size exclusion chromatography using the
Superdex-200 column (GE Healthcare) in 20 mM Tris-Cl pH 8.0 and 200 mM KCl. Protein samples
were concentrated to 2–14 mg ml 1 and flash-frozen in liquid nitrogen. Point mutants were gener-
ated in the baculovirus shuttle vectors using the QuikChange site-directed mutagesis protocol.
Mutant proteins were expressed and as for the WT construct.
For crystallization, the truncated complex containing METTL3 (residues 354–580) and METTL14
(residues 107–395) was prepared by coexpression in Sf9 cells using the 5B baculovirus shuttle vector.
In this case, METTL14 carried an N-terminal hexahistidine tag while METTL3 was expressed without
an affinity tag. The truncated complex was expressed and purified as for full-length METTL3-
METTL14. The sample was concentrated to 11 mg ml 1 and flash-frozen in liquid nitrogen. The par-
tially truncated complexes comprising full-length METTL3 and truncated METTL14 (residues 107–
395), or truncated METTL3 (residues 354–580) and full-length METTL14, were prepared according to
the same procedure.
Limited proteolysis
The full length METTL3-METTL14 complex was diluted to 1.0 mg ml 1 and incubated overnight at
4˚C with chymotrypsin at a ratio of 100:1 (w/w). The resulting protein sample was analyzed by SDS-
PAGE and subjected to size exclusion chromatography using the Superdex-200 column and 20 mM
TRIS pH 8.0, 200 mM KCl buffer. The fractions containing the truncated writer complex were pooled,
concentrated and subjected to mass spectrometry and N-terminal Edman sequencing analysis at
Functional Genomics Center Zurich.
Crystallization and structure determination
Purified METTL3354–580-METTL14106–396 complex was diluted to 5 mg ml 1 in 10 mM Tris-Cl pH 8.0,
200 mM KCl. Crystals were obtained using the hanging drop vapor diffusion method by mixing 1 ml
complex solution with 1 ml reservoir solution containing 100 mM sodium cacodylate pH 6.5, 100 mM
Mg-acetate, 19% PEG 8000 (w/v). For data collection, crystals were cryoprotected by transfer to a
solution containing 100 mM sodium cacodylate pH 6.5, 100 mM Mg acetate, 20% (w/v) PEG 8000,
and 15% (v/v) glycerol, and flash cooled in liquid nitrogen. X-ray diffraction data were collected at
beam line X06DA (PXIII) of the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland) and
processed using XDS (Kabsch, 2010). Data collection statistics are shown in Table 1. Native sulfur-
SAD data comprised 11 data sets collected by exposing different parts of the same crystal, rotating
the crystal through 360˚ in each data set and changing the kappa angle between datasets in 5˚ incre-
ments to ensure data completeness and redundancy. Sulfur sites were located using SHELXD
(Schneider and Sheldrick, 2002), and phases were calculated using SHELXE (Sheldrick, 2008). The
model was subsequently improved using the phenix.autobuild routine (Zwart et al., 2008), followed
by several rounds of manual building in Coot (Emsley and Cowtan, 2004) and refinement using
phenix.refine (Afonine et al., 2012). Crystals used for the high-resolution native dataset collection
were grown in the presence 0.5 mM SAH and 1 mM RNA oligonucleotide (CUGG-m6A-CUAA) or
with 5 mM SAM, respectively, from 18–22% (w/v) PEG 3350 and 300 mM Mg-acetate. Substrate-
bound structures were determined by molecular replacement using the Phaser module of the Phenix
package. Model building and refinement was carried out using COOT and phenix.refine.
Methyltransferase activity assays
Methyltransferase activities of wild-type and mutant METTL3-METTL14 complexes were measured
using an antibody-based assay. Assay conditions were derived from a previously reported radioactiv-
ity-based assay (Li et al., 2016) and modified to ensure optimal turnover within the timescale of the
assay. Reactions mixtures contained 200 nM 3’-biotinylated RNA substrate (5’-UACACUCGAUC
UGGACUAAGCUGCUC-3’) and 1 mM S-adenosyl methionine in 20 mM Tris buffer at pH 8.0. The
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reactions were initiated by the addition of 100 nM protein and incubated at 37˚C for 180 min. To
detect the production of methylated RNA, reaction mixtures were transferred to the 96-well neutra-
vidin coated plates (Pierce) and incubated for 60 min at 4˚C. Following extensive washing and block-
ing, the plate was incubated first with a m6A-specific primary antibody (Abcam ab151230, used at
1:400 dilution), and subsequently with horseradish peroxidase-conjugated secondary antibody
(Sigma-Aldrich, A6154, used at 1:5000 dilution). m6A antibody binding was quantified by measuring
the conversion of a colorimetric substrate 3,3’,5,5’-tetramethylbenzidine (TMB, supplied as BM Blue
POD substrate by Roche Diagnostics GmbH, Germany) at a wavelength of 390 nm. Reactions lacking
the SAM cofactor were performed to measure the background signal for each enzyme construct due
to non-specific antibody binding.
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